Current status in diabetic macular edema treatments.
暂无分享,去创建一个
[1] Judy E. Kim,et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. , 2009, Archives of ophthalmology.
[2] L. Claesson‐Welsh,et al. VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.
[3] Robert N. Johnson,et al. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. , 1991, Archives of ophthalmology.
[4] Ingrid U Scott,et al. Diabetic macular edema: what is focal and what is diffuse? , 2008, American journal of ophthalmology.
[5] B Kirchhof,et al. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.
[6] Mirjana Huic,et al. Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review , 2011, British Journal of Ophthalmology.
[7] Lloyd Paul Aiello,et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema , 2010, Ophthalmology.
[8] Ronald Klein,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. , 2009, Ophthalmology.
[9] J. Shaw,et al. Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.
[10] G. Bresnick,et al. DIABETIC MACULAR EDEMA: A REVIEW , 1986 .
[11] Pedro Romero-Aroca,et al. Managing diabetic macular edema: The leading cause of diabetes blindness. , 2011, World journal of diabetes.
[12] P. Romero-Aroca. Factores de riesgo y efecto de los fármacos administrados por vía sistémica sobre la retinopatía diabética , 2011 .
[13] Romero-Aroca Pedro,et al. Prevalence and Relationship Between Diabetic Retinopathy and Nephropathy, and its Risk Factors in the North-East of Spain, a Population-Based Study , 2010, Ophthalmic epidemiology.
[14] P. Romero-Aroca. Targeting the Pathophysiology of Diabetic Macular Edema , 2010, Diabetes Care.
[15] T. Yamamoto,et al. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. , 2001, American journal of ophthalmology.
[16] W. Smiddy. Economic considerations of macular edema therapies. , 2011, Ophthalmology.
[17] S. Kishi,et al. PROGRESSIVE ENLARGEMENT OF SCATTERED PHOTOCOAGULATION SCARS IN DIABETIC RETINOPATHY , 2004, Retina.
[18] J. Forrester,et al. Epidemiology of diabetic retinopathy and macular oedema: a systematic review , 2004, Eye.
[19] P. Romero-Aroca,et al. Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients. , 2009, Journal of diabetes and its complications.
[20] G. Bresnick. Diabetic maculopathy. A critical review highlighting diffuse macular edema. , 1983, Ophthalmology.
[21] Gary C. Brown,et al. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology. , 2012, Ophthalmology.
[22] H. Flynn,et al. PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR DIABETIC MACULAR EDEMA , 2008, Retina.
[23] F. Bandello,et al. Evidence for Anti-VEGF Treatment of Diabetic Macular Edema , 2012, Ophthalmic Research.
[24] Ronald Klein,et al. Changes in visual impairment prevalence by period of diagnosis of diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. , 2009, Ophthalmology.
[25] R. Brancato,et al. Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia. , 1990, Retina.
[26] R. Ramsay,et al. DIABETIC MACULAR EDEMA ASSOCIATED WITH GLITAZONE USE , 2006, Retina.